The Board of Directors of The IBN SINA Pharmaceutical Industry Ltd. has recommended 60% Cash Dividend for the year ended June 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
256.6 BDT | 0.00% | +1.14% | -10.47% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.47% | 73.02M | |
+19.98% | 43.67B | |
+20.67% | 22.51B | |
+14.56% | 14.6B | |
+14.32% | 13.74B | |
+44.72% | 11.91B | |
-8.37% | 7.04B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.42B |
- Stock Market
- Equities
- IBNSINA Stock
- News The IBN SINA Pharmaceutical Industry PLC
- The IBN SINA Pharmaceutical Industry Ltd. Recommends Cash Dividend for the Year Ended June 30, 2022